{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:33:28Z","timestamp":1793838808674,"version":"4.6.1"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.mce.2021.111261","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T23:56:04Z","timestamp":1616802964000},"page":"111261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["Steroidogenic cytochrome P450 17A1 structure and function"],"prefix":"10.1016","volume":"528","author":[{"given":"Sarah D.","family":"Burris-Hiday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2021.111261_bib1","doi-asserted-by":"crossref","first-page":"22080","DOI":"10.1074\/jbc.M112.448225","article-title":"A model of the membrane-bound cytochrome b5-cytochrome P450 complex from NMR and mutagenesis data","volume":"288","author":"Ahuja","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1042\/bj2010569","article-title":"Mechanistic studies on C-19 demethylation in oestrogen biosynthesis","volume":"201","author":"Akhtar","year":"1982","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2021.111261_bib3","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1021\/bi00180a039","article-title":"Mechanism of the acyl-carbon cleavage and related reactions catalyzed by multifunctional P-450s: studies on cytochrome P-450(17)alpha","volume":"33","author":"Akhtar","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111261_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jsbmb.2010.11.003","article-title":"A review of mechanistic studies on aromatase (CYP19) and 17alpha-hydroxylase-17,20-lyase (CYP17)","volume":"125","author":"Akhtar","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2021.111261_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-009-0436-8","article-title":"Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells","volume":"121","author":"Amicis","year":"2010","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.mce.2021.111261_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/jc.2011-2189","article-title":"Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer","volume":"97","author":"Attard","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111261_bib7","series-title":"Inhibitors of CYP17A1","author":"Aube","year":"2015"},{"key":"10.1016\/j.mce.2021.111261_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0889-8529(08)70021-5","article-title":"The genetics, pathophysiology, and management of human deficiencies of P450c17","volume":"30","author":"Auchus","year":"2001","journal-title":"Endocrinol Metab. Clin. N. Am."},{"key":"10.1016\/j.mce.2021.111261_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","article-title":"The backdoor pathway to dihydrotestosterone","volume":"15","author":"Auchus","year":"2004","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.mce.2021.111261_bib10","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-018-4813-z","article-title":"Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer","volume":"171","author":"Bardia","year":"2018","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.mce.2021.111261_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0169-328X(99)00002-9","article-title":"Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage","volume":"66","author":"Bastianetto","year":"1999","journal-title":"Brain Res. Mol."},{"key":"10.1016\/j.mce.2021.111261_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/138920209787581307","article-title":"The role of androgen receptor mutations in prostate cancer progression","volume":"10","author":"Brooke","year":"2009","journal-title":"Curr. Genom."},{"key":"10.1016\/j.mce.2021.111261_bib14","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1113\/jphysiol.2011.206078","article-title":"Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats","volume":"589","author":"Camporez","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.mce.2021.111261_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.120.265868","article-title":"Slow-, tight-binding inhibition of CYP17A1 by abiraterone redefines its kinetic selectivity and dosing regimen","volume":"374","author":"Cheong","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.mce.2021.111261_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.31","article-title":"Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma","volume":"6","author":"Chuang","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.mce.2021.111261_bib17","doi-asserted-by":"crossref","first-page":"13816","DOI":"10.1021\/bi971085s","article-title":"Redox control of the catalytic cycle of flavocytochrome P-450 BM3","volume":"36","author":"Daff","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111261_bib18","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2021.111261_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature10743","article-title":"Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001","volume":"482","author":"DeVore","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mce.2021.111261_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jsbmb.2016.07.009","article-title":"Androgen biosynthesis during minipuberty favors the backdoor pathway over the classic pathway: insights into enzyme activities and steroid fluxes in healthy infants during the first year of life from the urinary steroid metabolome","volume":"165","author":"Dhayat","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2021.111261_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1515\/cclm-2019-0693","article-title":"Biomarkers for prostate cancer: prostate-specific antigen and beyond","volume":"58","author":"Duffy","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.mce.2021.111261_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbrc.2016.06.043","article-title":"Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen synthesis","volume":"477","author":"Duggal","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2021.111261_bib23","doi-asserted-by":"crossref","first-page":"17008","DOI":"10.1074\/jbc.M113.468926","article-title":"Substrate-modulated cytochrome P450 17A1 and cytochrome b5 interactions revealed by NMR","volume":"288","author":"Estrada","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib24","doi-asserted-by":"crossref","first-page":"14310","DOI":"10.1074\/jbc.M114.560144","article-title":"Human cytochrome P450 17A1 conformational selection: modulation by ligand and cytochrome b5","volume":"289","author":"Estrada","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib25","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1021\/bi002681g","article-title":"Structural and dynamic perturbations induced by heme binding in cytochrome b5","volume":"40","author":"Falzone","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111261_bib26","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/me.2015-1012","article-title":"COPII-dependent ER export: a critical component of insulin biogenesis and \u03b2-cell ER homeostasis","volume":"29","author":"Fang","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2021.111261_bib27","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1021\/acs.jmedchem.8b00419","article-title":"Structure-based design of inhibitors with improved selectivity for steroidogenic cytochrome P450 17A1 over cytochrome P450 21A2","volume":"61","author":"Fehl","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.2014.56.5119","volume":"33","author":"Fizazi","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mce.2021.111261_bib29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(12)70379-0","article-title":"Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study","volume":"13","author":"Fizazi","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mce.2021.111261_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5534\/wjmh.180040","article-title":"Role of androgen receptor in prostate cancer: a review","volume":"37","author":"Fujita","year":"2019","journal-title":"World J. Mens. Health"},{"key":"10.1016\/j.mce.2021.111261_bib31","doi-asserted-by":"crossref","first-page":"20404","DOI":"10.1074\/jbc.M601785200","article-title":"Identification of the interactions between cytochrome P450 2E1 and cytochrome b5 by mass spectrometry and site-directed mutagenesis","volume":"281","author":"Gao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2014.01.013","article-title":"A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone","volume":"143","author":"Garrido","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2021.111261_bib33","doi-asserted-by":"crossref","first-page":"13168","DOI":"10.1074\/jbc.M117.794917","article-title":"Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1","volume":"292","author":"Gonzalez","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1074\/jbc.RA117.000504","article-title":"Inherent steroid 17alpha,20-lyase activity in defunct cytochrome P450 17A enzymes","volume":"293","author":"Gonzalez","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib35","doi-asserted-by":"crossref","first-page":"16245","DOI":"10.1021\/ja4086403","article-title":"Kinetic solvent isotope effect in human P450 CYP17A1-mediated androgen formation: evidence for a reactive peroxoanion intermediate","volume":"135","author":"Gregory","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mce.2021.111261_bib36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1021\/acs.biochem.7b01067","article-title":"Human P450 CYP17A1: control of substrate preference by asparagine 202","volume":"57","author":"Gregory","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111261_bib37","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1021\/bi00281a007","article-title":"Oxidation-reduction properties of rat liver cytochromes P-450 and NADPH-cytochrome p-450 reductase related to catalysis in reconstituted systems","volume":"22","author":"Guengerich","year":"1983","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111261_bib38","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1016\/S0021-9258(19)40959-9","article-title":"Purified liver microsomal cytochrome P-450. Electron-accepting properties and oxidation-reduction potential","volume":"250","author":"Guengerich","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib39","doi-asserted-by":"crossref","first-page":"10028","DOI":"10.1074\/jbc.RA119.008860","article-title":"Conformational selection dominates binding of steroids to human cytochrome P450 17A1","volume":"294","author":"Guengerich","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib40","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jmb.2010.05.069","article-title":"Molecular modeling on inhibitor complexes and active-site dynamics of cytochrome P450 C17, a target for prostate cancer therapy","volume":"400","author":"Haider","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mce.2021.111261_bib41","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1021\/jm040202w","article-title":"Novel C-17-heteroaryl steroidal CYP17 inhibitors\/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model","volume":"48","author":"Handratta","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10549-008-9923-6","article-title":"Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor","volume":"112","author":"Harvell","year":"2008","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.mce.2021.111261_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0003-9861(71)90186-X","article-title":"Evidence for the participation of cytochrome b5 in hepatic microsomal mixed-function oxidation reactions","volume":"143","author":"Hildebrandt","year":"1971","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mce.2021.111261_bib44","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2005-2460","article-title":"Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone","volume":"91","author":"Homma","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111261_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.abb.2010.10.023","article-title":"The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5)","volume":"507","author":"Im","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mce.2021.111261_bib46","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1021\/bi00705a023","article-title":"Redox properties of the reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 and reduced nicotinamide adenine dinucleotide-cytochrome b5 reductases","volume":"13","author":"Iyanagi","year":"1974","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111261_bib47","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1021\/jm981017j","article-title":"The 16,17-double bond is needed for irreversible inhibition of human cytochrome p45017alpha by abiraterone (17-(3-pyridyl)androsta-5, 16-dien-3beta-ol) and related steroidal inhibitors","volume":"41","author":"Jarman","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib48","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1074\/jbc.R113.452805","article-title":"Structural diversity of eukaryotic membrane cytochrome P450s","volume":"288","author":"Johnson","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib49","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1016\/j.bmc.2011.08.066","article-title":"Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer","volume":"19","author":"Kaku","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jc.2011-1997","article-title":"Increased activation of the alternative \"backdoor\" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis","volume":"97","author":"Kamrath","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111261_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.134","article-title":"DNA damage induces reactive oxygen species generation through the H2AX-Nox1\/Rac1 pathway","volume":"3","author":"Kang","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mce.2021.111261_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/abbi.1995.1173","article-title":"The role of cytochrome b5 in the biosynthesis of androgens by human P450c17","volume":"317","author":"Katagiri","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mce.2021.111261_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2013.11.094","article-title":"Active site proton delivery and the lyase activity of human CYP17A1","volume":"443","author":"Khatri","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2021.111261_bib54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/jc.2011-0640","article-title":"Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency","volume":"97","author":"Krone","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111261_bib55","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/0959-8049(96)00112-8","article-title":"The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters","volume":"32","author":"Kuenen-Boumeester","year":"1996","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.mce.2021.111261_bib56","first-page":"4499","article-title":"Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease","volume":"62","author":"LaTulippe","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2021.111261_bib57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/bj3320293","article-title":"Control of androgen biosynthesis in the human through the interaction of Arg347 and Arg358 of CYP17 with cytochrome b5","volume":"332","author":"Lee-Robichaud","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2021.111261_bib58","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1021\/bi00043a015","article-title":"Mechanistic kinship between hydroxylation and desaturation reactions: acyl-carbon bond cleavage promoted by pig and human CYP17 (P-450(17)alpha; 17 alpha-hydroxylase-17,20-lyase)","volume":"34","author":"Lee-Robichaud","year":"1995","journal-title":"Biochemistry"},{"issue":"Pt 3","key":"10.1016\/j.mce.2021.111261_bib59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/bj3080901","article-title":"Modulation of the activity of human 17 alpha-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications","volume":"308","author":"Lee-Robichaud","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2021.111261_bib60","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nsb0297-140","article-title":"The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid","volume":"4","author":"Li","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.mce.2021.111261_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091378","article-title":"CYP17A1 maintains the survival of glioblastomas by regulating SAR1-mediated endoplasmic reticulum Health and redox homeostasis","volume":"11","author":"Lin","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.mce.2021.111261_bib62","first-page":"258","article-title":"Phase 2 study of seviteronel (INO-464) in patients with metastatic castration-resistant prostate cancer after enzalutamide treatment","volume":"18","author":"Madan","year":"2020","journal-title":"Clin. Genitourin. Canc."},{"key":"10.1016\/j.mce.2021.111261_bib63","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1021\/jacs.8b03901","article-title":"Human cytochrome CYP17A1: the structural basis for compromised lyase activity with 17-hydroxyprogesterone","volume":"140","author":"Mak","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mce.2021.111261_bib64","doi-asserted-by":"crossref","first-page":"15856","DOI":"10.1073\/pnas.1519376113","article-title":"Unveiling the crucial intermediates in androgen production","volume":"112","author":"Mak","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2021.111261_bib65","first-page":"3382","volume":"84","author":"Mapes","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111261_bib66","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mce.2016.07.029","article-title":"Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome","volume":"441","author":"Marti","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2021.111261_bib67","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1200\/JCO.2006.09.0118","article-title":"Plasma testosterone and prognosis of postmenopausal breast cancer patients","volume":"25","author":"Micheli","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mce.2021.111261_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2021.111261_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000198","article-title":"The \u201cbackdoor pathway\u201d of androgen synthesis in human male sexual development","volume":"17","author":"Miller","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.mce.2021.111261_bib70","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1021\/jacs.9b00242","article-title":"Reduction potentials of P450 compounds I and II: insight into the thermodynamics of C-H bond activation","volume":"141","author":"Mittra","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mce.2021.111261_bib71","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncr.11532","article-title":"Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies","volume":"98","author":"Moinfar","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2021.111261_bib72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0090-9556(25)07730-X","article-title":"Effects of cytochrome b5 on cytochrome P-450-catalyzed reactions. Studies with manganese-substituted cytochrome b5","volume":"12","author":"Morgan","year":"1984","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.mce.2021.111261_bib73","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbrc.2017.06.137","article-title":"Inhibition of PLD1 activity causes ER stress via regulation of COPII vesicle formation","volume":"490","author":"Nakagawa","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2021.111261_bib74","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/S0021-9258(19)69538-4","article-title":"Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase)","volume":"256","author":"Nakajin","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib75","unstructured":"Njar, V."},{"key":"10.1016\/j.mce.2021.111261_bib76","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1172\/JCI87328","article-title":"Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer","volume":"127","author":"Norris","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2021.111261_bib77","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/annonc\/mdv487","article-title":"Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer","volume":"27","author":"O'Shaughnessy","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mce.2021.111261_bib78","article-title":"Alternative (backdoor) androgen production and masculinization in the human fetus","volume":"17","author":"O'Shaughnessy","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.mce.2021.111261_bib79","doi-asserted-by":"crossref","first-page":"8935","DOI":"10.1016\/S0021-9258(18)34223-6","article-title":"Oxidation-reduction states of FMN and FAD in NADPH-cytochrome-P-450 reductase during reduction by NADPH","volume":"257","author":"Oprian","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib80","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1021\/acs.biochem.6b00532","article-title":"Cytochrome b(5) activates the 17,20-lyase activity of human cytochrome P450 17A1 by increasing the coupling of NADPH consumption to androgen production","volume":"55","author":"Peng","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111261_bib81","doi-asserted-by":"crossref","first-page":"32952","DOI":"10.1074\/jbc.M114.610998","article-title":"Structures of human steroidogenic cytochrome P450 17A1 with substrates","volume":"289","author":"Petrunak","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib82","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/dmd.117.075317","article-title":"Structural and functional evaluation of clinically relevant inhibitors of steroidogenic cytochrome P450 17A1","volume":"45","author":"Petrunak","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.mce.2021.111261_bib83","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1021\/jm00013a022","article-title":"Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer","volume":"38","author":"Potter","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib84","series-title":"Cytochrome P450: Structure, Mechanism, and Biochemistry","first-page":"12","article-title":"Structures of cytochrome P450 enzymes","author":"Poulos","year":"2015"},{"key":"10.1016\/j.mce.2021.111261_bib85","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.bmcl.2014.04.024","article-title":"Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors","volume":"24","author":"Rafferty","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.mce.2021.111261_bib86","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10637-016-0403-2","article-title":"Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer","volume":"35","author":"Rampurwala","year":"2017","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.mce.2021.111261_bib87","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.8342039","article-title":"Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's","volume":"261","author":"Ravichandran","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.mce.2021.111261_bib88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00195006","article-title":"Sexual differentiation of the urogenital system of the fetal and neonatal tammar wallaby, Macropus eugenii","volume":"194","author":"Renfree","year":"1996","journal-title":"Anat. Embryol."},{"key":"10.1016\/j.mce.2021.111261_bib89","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1095\/biolreprod47.4.644","article-title":"Steroid hormone content of the gonads of the tammar wallaby during sexual differentiation","volume":"47","author":"Renfree","year":"1992","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.mce.2021.111261_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00801","article-title":"Second-generation antiandrogens: from discovery to standard of care in castration resistant prostate cancer","volume":"9","author":"Rice","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mce.2021.111261_bib91","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1038\/emboj.2011.216","article-title":"Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1","volume":"30","author":"Robinson","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2021.111261_bib92","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1021\/jm00021a008","article-title":"Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase\/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysis","volume":"38","author":"Rowlands","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib93","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1470-2045(15)70027-6","article-title":"Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial","volume":"16","author":"Saad","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mce.2021.111261_bib94","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.febslet.2007.01.091","article-title":"Mechanisms of COPII vesicle formation and protein sorting","volume":"581","author":"Sato","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2021.111261_bib95","series-title":"Dioxygen-dependent Heme Enzymes","first-page":"249","article-title":"Structures of human cytochrome P450 enzymes: variations on a theme","author":"Scott","year":"2018"},{"key":"10.1016\/j.mce.2021.111261_bib96","doi-asserted-by":"crossref","first-page":"13196","DOI":"10.1073\/pnas.2133986100","article-title":"An open conformation of mammalian cytochrome P450 2B4 at 1.6-angstrom resolution","volume":"100","author":"Scott","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2021.111261_bib97","doi-asserted-by":"crossref","first-page":"27294","DOI":"10.1074\/jbc.M403349200","article-title":"Structure of mammalian cytochrome P4502B4 complexed with 4-(4-chlorophenyl) imidazole at 1.9-angstrom resolution - insight into the range of P450 conformations and the coordination of redox partner binding","volume":"279","author":"Scott","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib98","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajmg.a.30104","article-title":"Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis","volume":"128","author":"Shackleton","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.mce.2021.111261_bib99","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1242\/dev.104.4.689","article-title":"Experimental manipulation of sexual differentiation in wallaby pouch young treated with exogenous steroids","volume":"104","author":"Shaw","year":"1988","journal-title":"Development"},{"key":"10.1016\/j.mce.2021.111261_bib100","doi-asserted-by":"crossref","first-page":"12445","DOI":"10.1074\/jbc.271.21.12445","article-title":"The mechanism of the acyl-carbon bond cleavage reaction catalyzed by recombinant sterol 14 alpha-demethylase of Candida albicans (other names are: lanosterol 14 alpha-demethylase, P-45014DM, and CYP51)","volume":"271","author":"Shyadehi","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib101","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1021\/bi00669a029","article-title":"Coupling of spin, substrate, and redox equilibria in cytochrome P450","volume":"15","author":"Sligar","year":"1976","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111261_bib102","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0006-291X(79)91916-8","article-title":"Spin state control of the hepatic cytochrome P450 redox potential","volume":"90","author":"Sligar","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2021.111261_bib103","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1046\/j.1432-1033.2003.03508.x","article-title":"Assessment of porcine and human 16-ene-synthase, a third activity of P450c17, in the formation of an androstenol precursor. Role of recombinant cytochrome b5 and P450 reductase","volume":"270","author":"Soucy","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.mce.2021.111261_bib104","doi-asserted-by":"crossref","first-page":"20079","DOI":"10.1021\/jacs.9b08561","article-title":"Quantum-mechanical\/molecular-mechanical studies of CYP11A1-catalyzed biosynthesis of pregnenolone from cholesterol reveal a C-C bond cleavage reaction that occurs by a compound I-mediated electron transfer","volume":"141","author":"Su","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mce.2021.111261_bib105","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2265.2000.01144.x","article-title":"Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies","volume":"53","author":"Suzuki","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.mce.2021.111261_bib106","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jsbmb.2009.12.014","article-title":"A single amino acid residue, Ala 105, confers 16alpha-hydroxylase activity to human cytochrome P450 17alpha-hydroxylase\/17,20 lyase","volume":"119","author":"Swart","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2021.111261_bib107","first-page":"98","article-title":"Progesterone 16 alpha-hydroxylase activity is catalyzed by human cytochrome P450 17 alpha-hydroxylase","volume":"77","author":"Swart","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111261_bib108","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/j.2040-4603.2014.tb00590.x","article-title":"Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions","volume":"4","author":"Turcu","year":"2014","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.mce.2021.111261_bib109","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/jc.2015-1023","article-title":"Profiles of 21-carbon steroids in 21-hydroxylase deficiency","volume":"100","author":"Turcu","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111261_bib110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cen.13414","article-title":"A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome","volume":"87","author":"Valassi","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.mce.2021.111261_bib111","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1073\/pnas.93.10.4644","article-title":"Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4","volume":"93","author":"Vaz","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2021.111261_bib112","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt319","article-title":"Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis","volume":"106","author":"Vera-Badillo","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mce.2021.111261_bib113","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jsbmb.2012.01.001","article-title":"Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys","volume":"129","author":"Yamaoka","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2021.111261_bib114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1507\/endocrj.45.89","article-title":"Immunohistochemical study of cytochrome b5 in human adrenal gland and in adrenocortical adenomas from patients with Cushing's syndrome","volume":"45","author":"Yanase","year":"1998","journal-title":"Endocr. J."},{"key":"10.1016\/j.mce.2021.111261_bib115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsbmb.2014.11.026","article-title":"The diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1)","volume":"151","author":"Yoshimoto","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2021.111261_bib116","doi-asserted-by":"crossref","first-page":"17143","DOI":"10.1074\/jbc.M116.732966","article-title":"Mechanism of 17alpha,20-lyase and new hydroxylation reactions of human cytochrome P450 17A1: 18O labeling and oxygen surrogate evidence for a role of a perferryl oxygen","volume":"291","author":"Yoshimoto","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111261_bib117","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1021\/ja508185d","article-title":"Mechanism of the third oxidative step in the conversion of androgens to estrogens by cytochrome P450 19A1 steroid aromatase","volume":"136","author":"Yoshimoto","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mce.2021.111261_bib118","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1021\/bi300895w","article-title":"Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates","volume":"51","author":"Yoshimoto","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2021.111261_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2012.00186","article-title":"Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma","volume":"2","author":"Yoshimoto","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mce.2021.111261_bib120","first-page":"121","article-title":"Current trends in the surgical management and treatment of adult glioblastoma","volume":"3","author":"Young","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.mce.2021.111261_bib121","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.3535074","article-title":"Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells","volume":"234","author":"Zuber","year":"1986","journal-title":"Science"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721001052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721001052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:17:43Z","timestamp":1759587463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720721001052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":121,"alternative-id":["S0303720721001052"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2021.111261","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroidogenic cytochrome P450 17A1 structure and function","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2021.111261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111261"}}